# Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days

> **NCT00686179** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 75 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD3480
- **DRUG:** Moxifloxacin
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT00686179
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2008-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686179, "Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00686179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*